• Nie Znaleziono Wyników

Clinical vignettes on COVID-19

N/A
N/A
Info
Pobierz
Protected

Academic year: 2022

Share "Clinical vignettes on COVID-19"

Copied!
2
0
0

Ładowanie.... (Zobacz pełny tekst teraz)

Pobierz teraz ( 2 Stron )

Pełen tekst

(1)

LETTER TO READERS

Dear Collegues,

The current SARS-CoV-2 virus (COVID-19) pandemic has become one of the greatest health challenges facing the world in 2020. Cancer patients are a heterogeneous group, and the type of systemic and local treatment may affect their immune response and the course of any infection.

In the group of high risk of severe course of SARS-CoV-2 infection, there are undoubtedly cancer patients with many comorbidities, especially cardiovascular and pulmonary diseases, in old age and in the advanced stage of the disease. Although the impact of oncological treatment on the course of SARS-CoV-2 infection remains unclear, international guidelines recommend postponing chemotherapy or elective surgery in specific indications in endemic areas. During the SARS-CoV-2 pandemic, the oncological community continued its work despite numerous challenges in the functioning of medical care. To meet the expectations of our community and to present and analyze our own experience in cancer patients therapy and SARS-CoV-2 infection, the Oncology in Clinical Practice journal invites you to submit short case reports in the Clinical vignettes on COVID-19 format.

We hope that the presented clinical experiences will contribute to the improvement of cancer care.

Prof. dr hab. n. med. Renata Duchnowska Editor of Clinical vignettes on COVID-19

(2)

Cytaty

Pobierz teraz ( PDF - 2 Stron - 28.98 KB )

Powiązane dokumenty

Clinical outcome, viral response and safety profile of chloroquine in COVID-19 patients — initial experience

who assessed the efficacy and safety of HCQ in 150 Chinese patients where they found that the negative conversion of RT-PCR was similar for their standard care group as well as

SARS-CoV-2 infection: etiopathogenesis, clinical picture, current therapeutic options – the author’s observations

Stage I of COVID-19 disease – an asymptomatic patient or with a subclinical infection (applies to 80% of all infected persons) does not require hospitalisation, and therapeutic

Diagnostics and treatment of small intestine tumors in our own experience

Analysis of incidence, clinical symptoms, diagnostic methods and results of treatment of small intestine tumors in the material of the Maria Skłodowska-Curie Institute —

Clinical and genetic profile of patients with medullary thyroid cancer treated in the Cancer Centre - Institute of Oncology in Warsaw

Wstęp: Celem pracy jest analiza wyników badań genetycz- nych: rozkładu lokalizacji i częstości mutacji oraz ujawnie- nie korelacji prezentowanych klinicznie fenotypów u cho- rych

SARS-CoV infection and pregnancy

U pacjentów z SARS obserwowany jest wczesny wzrost poziomu cytokin IL-1β, IL-6,IL-12,INFγ, które mogà byç przyczynà aktywacji przez SARS-CoV komórek Th1 i NK (natural killers –

Atrial fibrillation is related to higher mortality in COVID-19/SARS-CoV-2 pneumonia infection

We retrospectively analyzed the patients diagnosed with COVID-19 pneumonia (symp- toms, positive nasopharyngeal swab and typical radiological feature) admitted to the Emergency

Metformin therapy and severity and mortality of SARS-CoV-2 infection: a meta-analysis

The present study found that the previous use of metformin in patients with type 2 diabetes is associated with lower risk of mortality from SARS-CoV-2 infection but not with

SARS-CoV uses ACE2 and CD209L receptors in infection

Diabetes alters NK cell phenotype and function; in fact, patients with type 2 diabetes have an abnormal NK cell phenotype with a significant decrease in frequency of both NKp46-